v3.24.0.1
Stockholders’ Equity (Details) - Part-1 - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 13, 2022
Aug. 17, 2023
Apr. 20, 2023
Dec. 20, 2022
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Jul. 11, 2023
Jul. 19, 2022
Oct. 18, 2021
May 24, 2021
Feb. 24, 2021
Jul. 19, 2019
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Common stock, par value (in Dollars per share)                               $ 0.001    
Reverse stock split, description 1 for 50 1 for 40             On September 13, 2022, the Company effectuated a 1 for 50 reverse stock split (the “2022 Reverse Split”).                  
Company issued shares (in Shares)                 4,675   3,707 31            
Stock based compensation for consulting services         $ 168,300 $ 250,000 $ 3,719 $ 168,300   $ 507,558 $ 336,117            
Restricted stock granted (in Shares)                 170                  
Stock-based compensation expense                 $ 24,429   $ 105,049 $ 587,209            
Aggregate offering share price       $ 50,000,000                            
Sale of share price (in Dollars per share)                           $ 0.001 $ 3,000      
Net proceeds paying commissions                 $ 507,016                  
Preferred stock, shares authorized (in Shares)                 3,000,000   3,000,000 3,000,000            
Common stock, par value (in Dollars per share)                 $ 0.001   $ 0.001 $ 0.001            
Preferred stock outstanding (in Shares)                 0   0 0   250,000,000       250,000,000
At The Market Offerings [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Sale of shares (in Shares)                 8,466                  
Sale of share price (in Dollars per share)                 $ 62.05                  
Minimum [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Common stock, shares authorized (in Shares)                               27,000,000    
Aggregate gross sales     $ 0                              
Maximum [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Common stock, shares authorized (in Shares)                               100,000,000    
Aggregate gross sales     $ 50,000,000                              
Common Stock [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Common stock, par value (in Dollars per share)                 $ 0.001   $ 0.001 $ 0.001         $ 0.001  
Common stock, shares authorized (in Shares)                 100,000,000   100,000,000 100,000,000            
Common stock issued to exercise of prefunded warrants (in Shares)                 (184,374)                  
Preferred Stock [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Preferred stock, shares authorized (in Shares)                 3,000,000                  
Preferred stock outstanding (in Shares)                     250,000,000          
Restricted Stock Units [Member]                                    
Stockholders’ Equity (Details) - Part-1 [Line Items]                                    
Company issued shares (in Shares)                   413                
Restricted stock units (in Shares)                 170                  
Recognized expenses                 $ 308,479 $ 253,719                
Restricted stock granted (in Shares)                 170 291                
Restricted stock vested (in Shares)           379     0 379                
Stock-based compensation expense                   $ 993,462 $ 848,597